Vasopressin deficiency and vasodilatory state in end-stage liver disease. - Wikidata - wikimedia - TriplyDB

Vasopressin deficiency and vasodilatory state in end-stage liver disease.

Vasopressin deficiency and vasodilatory state in end-stage liver disease.

http://www.wikidata.org/entity/Q35118679

about

Postreperfusion syndrome during liver transplantation Hepatosplanchnic circulation in cirrhosis and sepsis Vasopressin use in critically ill cirrhosis patients with catecholamine-resistant septic shock: The CVICU cohort.Current clinical management of pulmonary arterial hypertension Bench-to-bedside review: Vasopressin in the management of septic shock Liver transplantation: Advances and perioperative care.Performance measurement of intraoperative systolic arterial pressure to predict in-hospital mortality in adult liver transplantation.Vasopressin-induced changes in splanchnic blood flow and hepatic and portal venous pressures in liver resection.Visual quality assessment of the liver graft by the transplanting surgeon predicts postreperfusion syndrome after liver transplantation: a retrospective cohort study.

P2860

Q26774922-41FAB887-BDFE-40FB-B5DC-C1B8B36A5385 Q26864350-C99899BA-0CF1-403D-AF8E-E00C681E84EB Q30274871-F841B94F-A524-457D-A0F6-A5E83BFAD7B6 Q35673783-894C3CB4-EEFE-4F1F-B173-70096B326842 Q36070556-F42838B4-731E-4F65-AC68-FD1138868CD5 Q36313395-0DC8A73B-5258-4850-B187-1E7BEC300FD8 Q41203696-2009D9A3-E1F4-489C-8DB4-2B8EC062A347 Q47604231-70634AAB-8590-4E1B-8E69-1616DDD6876E Q55084625-346D3905-D4E2-4A4B-84CB-569608E757CE

P2860

Vasopressin deficiency and vasodilatory state in end-stage liver disease.

http://www.wikidata.org/entity/Q35118679

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Vasopressin deficiency and vasodilatory state in end-stage liver disease.

@ast

Vasopressin deficiency and vasodilatory state in end-stage liver disease.

@en

type

label

Vasopressin deficiency and vasodilatory state in end-stage liver disease.

@ast

Vasopressin deficiency and vasodilatory state in end-stage liver disease.

@en

prefLabel

Vasopressin deficiency and vasodilatory state in end-stage liver disease.

@ast

Vasopressin deficiency and vasodilatory state in end-stage liver disease.

@en

P1433

Q35118679-2EEFA234-3FED-4D06-A56B-23AB566E9F91

P1476

Q35118679-BD249571-3B83-487F-ACA5-C148A0F8C735

P2093

Q35118679-0D4A9355-A38D-4903-9293-AE449FAC184A

Q35118679-185559B5-D2EC-4E44-A0C0-00CC1C4C57CD

Q35118679-48A2A638-AD46-4D1C-BDD3-76F147C45B75

Q35118679-5C7407FF-6386-42EB-96C4-C958301A6884

Q35118679-E6B0CE61-55AD-414C-910B-19AEB1CD8A57

Q35118679-FA026AE7-38B7-4649-B07B-BD40C2380D05

P2860

Q35118679-2D32436B-7D50-453A-8FD5-01C44805DE19

Q35118679-4184514C-8875-4EBC-8C15-460FE83ECAFB

Q35118679-48A6E7A5-5826-4446-8421-EAD7752D5F87

Q35118679-4F92E5A3-E825-4AAC-948C-56D8F5BCFB97

Q35118679-51B33270-7479-44EC-AC25-DF06AC17C61D

Q35118679-55D0F75F-6308-4365-BB18-92D7AF590F36

Q35118679-75242254-543D-422A-9C41-656E0F2E034D

Q35118679-83A6858F-ACAB-4422-875D-259824EC609F

Q35118679-8EA0B360-3239-428D-8D4F-8BC393CD4260

Q35118679-90A4FBBD-6BA3-488B-9739-A89DD83E4CBC

P304

Q35118679-9E8C9981-5781-4E00-A5BB-99351E55CBF5

P31

Q35118679-A54F9E91-48E9-406B-A977-A32CCFE2318A

P356

Q35118679-353AF0AA-9021-42B7-9260-C81D5B3AF452

P433

Q35118679-BEEF347B-1AC1-4337-9AB5-F5D65791BAC7

P478

Q35118679-3129AF88-ADC6-42F2-B971-AE1918CADAD6

P577

Q35118679-08B322BE-F60C-47A3-A319-8B70AE969274

P5875

Q35118679-F684DDDE-50F1-4159-9C20-DD35C5488D36

P698

Q35118679-750A0E0A-375D-4C64-B00F-7BE3E7246B8E

P921

Q35118679-18be8df9-3bc5-42ec-aa89-830d3e3a7043

P932

Q35118679-94ECB108-195A-482D-BB1B-216A3421A4FF

P356

J.JVCA.2010.09.018

P1433

Journal of Cardiothoracic and Vascular Anesthesia

P1476

Vasopressin deficiency and vasodilatory state in end-stage liver disease.

@en

P2093

Donald W Landry

http://www.w3.org/2001/XMLSchema#string

Fallon Mattis

http://www.w3.org/2001/XMLSchema#string

Galina Kovalevskaya

http://www.w3.org/2001/XMLSchema#string

Gebhard Wagener

http://www.w3.org/2001/XMLSchema#string

Jean C Emond

http://www.w3.org/2001/XMLSchema#string

Moury Minhaz

http://www.w3.org/2001/XMLSchema#string

P2860

Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study.

Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis.

Update on peripheral arterial vasodilation, ascites and hepatorenal syndrome in cirrhosis.

The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series.

The pathogenesis of vasodilatory shock.

The pressor effect of the antidiuretic principle of the posterior pituitary in orthostatic hypotension.

Liver cirrhosis and arterial hypertension.

Vasoactive factors and hemodynamic mechanisms in the pathophysiology of portal hypertension in cirrhosis.

Terlipressin for hepatorenal syndrome: A meta-analysis of randomized trials.

Changes of vasopressin in hypertension: Cause or effect?

P304

665-670

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/J.JVCA.2010.09.018

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P577

2010-12-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49653807

http://www.w3.org/2001/XMLSchema#string

P698

21126886

http://www.w3.org/2001/XMLSchema#string

P921

P932

3140547

http://www.w3.org/2001/XMLSchema#string